We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Chimerix Inc
7 own
19 watching
Current Price
$1.82
$-0.02
(-1.09%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
160.24M
52-Week High
6.43
52-Week Low
1.27
Average Volume
0.7M
Dividend Yield
--
P/E Ratio
--
Market Capitalization160.24M52-Week High6.4352-Week Low1.27Average Volume0.7MDividend Yield--P/E Ratio--What does the Chimerix Inc do?
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company s approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs include ONC201 a program for treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients; ONC206, an imipridone, Dopamine Receptor D2 (DRD2) antagonist, and caseinolytic protease P (ClpP) agonist that demonstrated enhanced non-competitive DRD2 antagonism relative to ONC201, which is in Phase I clinical trials to treat solid tumors; ONC212, an imipridone agonist of the orphan G protein-coupled receptors (GPCR) tumor suppressor GPR132, as well as ClpP for solid tumors and hematological malignancies, including pancreatic cancer and leukemias; and dociparstat sodium (DSTAT), which inhibits the activities of key proteins implicated in the resistance of acute myeloid leukemia blasts and leukemic stem cells to chemotherapy. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; and SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.
Read More
How much money does Chimerix Inc make?
News & Events about Chimerix Inc.
Globe Newswire
1month ago
DURHAM, N.C., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Chimerix(NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that Mike Sherman, Chief Executive Officer, will present a ...
Business Wire
2 months ago
Rubric Capital Management LP (Rubric), an investment adviser whose managed funds and accounts collectively own approximately 8.5% of the common stock of Chimerix, Inc. (Chimerix or the Company) (NASDAQ: CMRX), today sent a letter to Chimerixs Board of Directors (the Board). In its letter, Rubric...
Globe Newswire
5 months ago
- Initial Procurement of 319,000 Treatment Courses for $115M with Additional Procurements at BARDAs Discretion Over 10 Years - Emergent BioSolutions, Inc. Payment Increases to $238M Upfront and $136.5M in Potential Milestones - DURHAM, N.C., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Chimerix(NASDAQ:CMRX), a...
PR Newswire
5 months ago
Demand for Comprehensive Cleaning Services Grow Post-Pandemic Demand for Comprehensive Cleaning Services Grow Post-Pandemic PR Newswire NEW YORK, Aug. 26, 2022 FinancialBuzz.com News Commentary NEW YORK, Aug. 26, 2022 /PRNewswire/ -- Due to the growing implementation of AI and automation in...
PR Newswire
6 months ago
Thinking about buying stock in Synthetic Biologics, Revelation Biosciences, Geovax Labs, Chimerix, or Zymergen? Thinking about buying stock in Synthetic Biologics, Revelation Biosciences, Geovax Labs, Chimerix, or Zymergen? PR Newswire NEW YORK, July 25, 2022 NEW YORK, July 25, 2022 /PRNewswire...
Frequently Asked Questions
Frequently Asked Questions
What is Chimerix Inc share price today?
Can Indians buy Chimerix Inc shares?
How can I buy Chimerix Inc shares from India?
Can Fractional shares of Chimerix Inc be purchased?
What are the documents required to start investing in Chimerix Inc stocks?
What is today’s traded volume of Chimerix Inc?
What is today’s market capitalisation of Chimerix Inc?
What is the 52-Week High and Low Range of Chimerix Inc?
What percentage is Chimerix Inc down from its 52-Week High?
What percentage is Chimerix Inc up from its 52-Week Low?
Current Price
$1.82
$-0.02
(-1.09%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.